h 256 has been researched along with h 142 in 2 studies
Studies (h 256) | Trials (h 256) | Recent Studies (post-2010) (h 256) | Studies (h 142) | Trials (h 142) | Recent Studies (post-2010) (h 142) |
---|---|---|---|---|---|
5 | 0 | 1 | 20 | 2 | 0 |
Protein | Taxonomy | h 256 (IC50) | h 142 (IC50) |
---|---|---|---|
Renin | Homo sapiens (human) | 0.001 | |
Cathepsin D | Bos taurus (cattle) | 0.007 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishchenko, AV; Shakhnovich, EI | 1 |
Atrash, B; Blundell, TL; Cooper, JB; Foundling, SI; Hallett, A; Hemmings, A; Jones, DM; Sibanda, BL; Szelke, M; Watson, FE | 1 |
2 other study(ies) available for h 256 and h 142
Article | Year |
---|---|
SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions.
Topics: Carbonic Anhydrases; Computing Methodologies; Databases, Factual; Ligands; Metalloendopeptidases; Metals; Molecular Conformation; Protein Binding; Proteins; Quantitative Structure-Activity Relationship; Statistics as Topic; Thermodynamics | 2002 |
Inhibitors of aspartic proteinases and their relevance to the design of antihypertensive agents.
Topics: Angiotensinogen; Antihypertensive Agents; Aspartic Acid Endopeptidases; Binding Sites; Endopeptidases; Humans; In Vitro Techniques; Models, Molecular; Molecular Conformation; Oligopeptides; Pepsin A; Protease Inhibitors; Renin | 1987 |